Toronto Dominion Bank
CRBP icon

Toronto Dominion Bank’s Corbus Pharmaceuticals CRBP Stock Holding History

Toronto Dominion Bank’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-143
Closed -$1K – 1521
2022
Q3 		$1K Buy
143
+28
+24% +$197 ﹤0.01% 1515
2022
Q2 		$1K Buy
115
+75
+188% +$725 ﹤0.01% 1240
2022
Q1 		$1K Sell
40
-70
-64% -$928 ﹤0.01% 1329
2021
Q4 		$2K Buy
+110
New +$2.98K ﹤0.01% 1436
2021
Q3 		– Hold
0
– – – 1391
2019
Q3 		– Sell
-6
Closed -$1K – 1486
2019
Q2 		$1K Buy
+6
New +$1.28K ﹤0.01% 1368

Other funds holding CRBP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Toronto Dominion Bank's CRBP Position: Q4 2022 in Review

Toronto Dominion Bank sold out of Corbus Pharmaceuticals (CRBP) in Q4 2022, closing a stake of 143 shares — an estimated $1K sold.

Toronto Dominion Bank first reported a position in CRBP in Q2 2019 and held it in 5 quarters. The position peaked at $2K in Q4 2021. 63 funds tracked by Wall St. Rank hold CRBP as of Q4 2022.

  • Toronto Dominion Bank reported no remaining Corbus Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Toronto Dominion Bank sold 143 Corbus Pharmaceuticals shares in Q4 2022, an estimated $1K.
  • Toronto Dominion Bank first reported a position in Corbus Pharmaceuticals in Q2 2019 and held it in 5 quarters.
  • Toronto Dominion Bank's Corbus Pharmaceuticals position peaked at $2K in Q4 2021.
  • 63 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2022.

Based on Toronto Dominion Bank's 13F filing for Q4 2022, filed 7 Feb 2023.